Product Information
HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET is a generic product labeled by Strides Pharma Inc., priced at $0.1351 per EA under NDC 64380044001. Its NADAC has been published 38 times since Oct 8, 2025.
Strength
325; 5 mg/1; mg/1
Manufacturer
Strides Pharma Inc.NDC
64380044001
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ACETAMINOPHEN; HYDROCODONE BITARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA202935On Market Since
9/1/2025
Pharmacological Classes
Price Statistics
The NADAC for HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET has been published 38 times since Oct 8, 2025, and over the history we have for it it has risen 6.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1351 per EA |
|---|---|
| All-time high | $0.1351 (Jun 24, 2026) |
| All-time low | $0.1273 (Oct 8, 2025) |
| 52-week high | $0.1351 |
| 52-week low | $0.1273 |
| Median price | $0.1291 |
| Average price | $0.1293 |
| Largest weekly change | +3.1% (Jun 17, 2026) |
| Weeks tracked | 38 |
| Tracking since | Oct 8, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the hydrocodone bitartrate and acetaminophen market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET, manufactured by Strides Pharma Inc., is $0.1351 per EA (NDC 64380044001), effective Jun 24, 2026.
How has the price of HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET changed over time?
Over the history we have for it, the NADAC for HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET has risen 6.2%. It has been tracked across 38 weekly CMS publications since Oct 8, 2025.
What are the highest and lowest recorded NADAC prices for HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET?
Since Oct 8, 2025, the NADAC for HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET has ranged from a low of $0.1273 (Oct 8, 2025) to a high of $0.1351 (Jun 24, 2026), with a median of $0.1291 per EA.
Are there cheaper alternatives to HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET?
HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET (NDC 64380044001) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification